Grading of Urologic Tumors: Is It Still Useful?

Bosman FT . The nuclear matrix in pathology. Virchows Arch. 1999; 435: 391–399.

Tang J , Niu JW , Xu DH , Li ZX , Li QF , Chen JA . Alteration of nuclear matrix-intermediate filament system and differential expression of nuclear matrix proteins during human hepatocarcinoma cell differentiation. World J Gastroenterol. 2007; 13: 2791–2797.

Fuhrman SA , Lasky LC , Limas C . Prognostic significance of morphologic parameters in renal cell carcinoma. Am J Surg Pathol. 1982; 6: 655–663.

Tsui KH , Shvarts O , Smith RB , Figlin RA , de Kernion JB , Belldegrun A . Prognostic indicators for renal cell carcinoma: a multivariate analysis of 643 patients using the revised 1997 TNM staging criteria. J Urol. 2000; 163: 1090–1095.

Algaba F . Prognostic factors of epithelial tumours of the kidney. Pathologica. 1999; 91: 51–53.

Al-Aynati M , Chen V , Salama S , Shuhaibar H , Treleaven D , Vincic L . Interobserver and intraobserver variability using the Fuhrman grading system for renal cell carcinoma. Arch Pathol Lab Med. 2003; 127: 593–596.

Bos SD , Mellema CT , Mensink HJ . Increase in incidental renal cell carcinoma in the northern part of the Netherlands. Eur Urol. 2000; 37: 267–270.

Gelb AB , Shibuya RB , Weiss LM , Medeiros LJ . Stage I renal cell carcinoma. A clinicopathologic study of 82 cases. Am J Surg Pathol. 1993; 17: 275–286.

Sika-Paotonu D , Bethwaite PB , McCredie MR , William Jordan T , Delahunt B . Nucleolar grade but not Fuhrman grade is applicable to papillary renal cell carcinoma. Am J Surg Pathol. 2006; 30: 1091–1096.

Delahunt B , Sika-Paotonu D , Bethwaite PB . Fuhrman grading is not appropriate for chromophobe renal cell carcinoma. Am J Surg Pathol. 2007; 31: 957–960.

Mostofi FK , Sobin LH , Torloni H . Histological Typing of Urinary Bladder Tumours (WHO International Histological Classification of Tumours, No. 10). Geneva, Switzerland: World Health Organization; (1973.

Millan-Rodriguez F , Chechile-Toniolo G , Salvador-Bayarri J , Palou J , Algaba F , Vicente-Rodriguez J . Primary superficial bladder cancer risk groups according to progression, mortality and recurrence. J Urol. 2000; 164: 680–684.

Lipponen P , Eskelinen M . Nuclear morphometry in grading transitional cell bladder cancer compared with subjective histological grading. Anticancer Res. 1990; 10: 1725–1730.

DiBonito L , Musse MM , Dudine S , Falconieri G . Cytology of transitional-cell carcinoma of the urinary bladder: diagnostic yield and histologic basis. Diagn Cytopathol. 1992; 8: 124–127.

Borland RN , Partin AW , Epstein JI , Brendler CB . The use of nuclear morphometry in predicting recurrence of transitional cell carcinoma. J Urol. 1993; 149: 272–275.

Eble JN , Sauter G , Epstein JI , Sesterhenn IA , eds. World Health Organization Classification of Tumours. Pathology and Genetics Tumours of the Urinary System and Male Genital Organs. Lyon, France: IARC Press; (2004.

Busch C , Algaba F . The WHO/ISUP 1998 and WHO 1999 systems for malignancy grading of bladder cancer. Scientific foundation and translation to one another and previous systems. Virchows Arch. 2002; 441: 105–108.

Bostwick DG , Mikuz G . Urothelial papillary (exophytic) neoplasms. Virchows Arch. 2002; 441: 109–116.

Carriaga MT , Henson DE . The histologic grading of cancer. Cancer. 1995; 75: 406–421.

Epstein JI , Allsbrook WC , Amin MB , Egevad LL ISUP Grading Committee. The 2005 International Society of Urological Pathology (ISUP) consensus conference on Gleason grading of prostatic carcinoma. Am J Surg Pathol. 2005; 29: 1228–1242.

Kallakury BV , Sheehan CE , Ross JS . C-downregulation of cell adhesion proteins alpha- and beta-catenins, p120CTN, E-cadherin, and CD44 in prostatic adenocarcinomas. Hum Pathol. 2001; 32: 849–855.

Bostwick DG . Pathology of prostate cancer. In: Ernstoff MS , Heaney JA , Peschel RE , eds. Urologic Cancer. Chichester, UK: Blackwell Science; 1997: 15–47.

Sebo TJ , Bock BJ , Cheville JC . The percent of cores positive for cancer in prostate needle biopsy specimens is strongly predictive of tumor stage and volume at radical prostatectomy. J Urol. 2000; 163: 174–178.

Paulson CF , Piserchia PV , Gardner W . Predictors of lymphatic spread in prostatic adenocarcinoma. J Urol. 1980; 123: 697–699.

Helpap B , Egevad L . The significance of modified Gleason grading of prostatic carcinoma in biopsy and radical prostatectomy specimens. Virchows Arch. 2006; 449: 622–627.

Slaton JW , Morgenstern N , Levy DA . Tumor stage, vascular invasion and the percentage of poorly differentiated cancer: independent prognosticators for inguinal node metastasis in penile squamous cancer. J Urol. 2001; 165: 1138–1142.

Rubio-Briones J , Villavicencio H , Regalado R . Squamous cell carcinoma of the penis: treatment protocol according to our 14 years experience. Arch Esp Urol. 1997; 50: 473–480.

Young RH , Srigley JR , Amin MB , Cubilla AL . Tumors of the Prostate Gland, Seminal Vesicles, Male Urethra and Penis (Fascicle, 3rd series). Washington, DC: Armed Forces Institute of Pathology; (2000.

Velazquez EF , Ayala GE , Liu H . Histologic grade and perineural invasion are more important than tumor thickness as predictor of nodal metastasis in penile squamous cell carcinoma invading 5-10 mm. Am J Surg Pathol. 2008; 32: 974–979.

Chaux A , Torres J , Pfannl R . Histological grade in penile squamous cell carcinoma. Visual estimation versus digital measurement of proportions of grades, adverse prognosis with any proportion of grade 3 and correlation of Gleason-like system with nodal metastasis. Am J Surg Pathol. 2009; 33: 1042–1048.